Tae Kyong Kim1, Jeong Jin Min2, Youn Joung Cho1, Derek J Hausenloy3, Hyuk Ahn4, Kyung-Hwan Kim4, Ho Young Hwang4, Deok Man Hong1, Yunseok Jeon5. 1. Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Republic of Korea. 2. Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Seoul, Republic of Korea. 3. The Hatter Cardiovascular Institute, University College London, London, UK; The National Institute of Health Research, University College London Hospitals Biomedical Research Center, London, UK; National Heart Research Institute Singapore, National Heart Center Singapore, Singapore, Singapore; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore, Singapore, Singapore. 4. Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Republic of Korea. 5. Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: jeonyunseok@gmail.com.
Abstract
BACKGROUND:Remote ischemic preconditioning (RIPC) has two time windows for organ protection: acute and delayed. Previous studies have mainly focused on the acute time window to evaluate organ protection by RIPC. We evaluated myocardial protection by delayed RIPC in adult patients undergoing cardiac surgery. METHODS: A total of 160 adult patients undergoing cardiac surgery with cardiopulmonary bypass were randomized to receive either delayed RIPC (four cycles of 5min of ischemia followed by 5min of reperfusion by inflation to 200mmHg and deflation of a blood pressure cuff on the upper arm) or the control treatment 24-48h before surgery. The primary endpoint was post-operative troponin I levels serially measured for 72h. Secondary endpoints included post-operative serum creatinine levels, acute kidney injury, and composite complications. RESULTS: There were no significant differences in post-operative troponin I values. The incidence of acute kidney injury, defined by the Acute Kidney Injury Network staging system, was lower in the delayed RIPC group compared to the control group (30.0% vs. 47.5%; relative risk, 0.768; 95% confidence interval, 0.599-0.985; p=0.023). Moreover, the occurrence of composite complications was lower in the delayed RIPC group compared with the control group (65.0% vs. 81.3%; relative risk, 0.536; 95% confidence interval, 0.311-0.924; p=0.020). CONCLUSIONS: While RIPC did not provide cardioprotective effects in patients undergoing cardiac surgery, it appeared to reduce acute kidney injury, as well as the rate of composite complications.
RCT Entities:
BACKGROUND: Remote ischemic preconditioning (RIPC) has two time windows for organ protection: acute and delayed. Previous studies have mainly focused on the acute time window to evaluate organ protection by RIPC. We evaluated myocardial protection by delayed RIPC in adult patients undergoing cardiac surgery. METHODS: A total of 160 adult patients undergoing cardiac surgery with cardiopulmonary bypass were randomized to receive either delayed RIPC (four cycles of 5min of ischemia followed by 5min of reperfusion by inflation to 200mmHg and deflation of a blood pressure cuff on the upper arm) or the control treatment 24-48h before surgery. The primary endpoint was post-operative troponin I levels serially measured for 72h. Secondary endpoints included post-operative serum creatinine levels, acute kidney injury, and composite complications. RESULTS: There were no significant differences in post-operative troponin I values. The incidence of acute kidney injury, defined by the Acute Kidney Injury Network staging system, was lower in the delayed RIPC group compared to the control group (30.0% vs. 47.5%; relative risk, 0.768; 95% confidence interval, 0.599-0.985; p=0.023). Moreover, the occurrence of composite complications was lower in the delayed RIPC group compared with the control group (65.0% vs. 81.3%; relative risk, 0.536; 95% confidence interval, 0.311-0.924; p=0.020). CONCLUSIONS: While RIPC did not provide cardioprotective effects in patients undergoing cardiac surgery, it appeared to reduce acute kidney injury, as well as the rate of composite complications.
Authors: M Joannidis; S J Klein; S John; M Schmitz; D Czock; W Druml; A Jörres; D Kindgen-Milles; J T Kielstein; M Oppert; V Schwenger; C Willam; A Zarbock Journal: Med Klin Intensivmed Notfmed Date: 2018-03-28 Impact factor: 0.840
Authors: Mandy Flechsig; Tobias F Ruf; Willi Troeger; Stephan Wiedemann; Silvio Quick; Karim Ibrahim; Christian Pfluecke; Akram Youssef; Krunoslav M Sveric; Robert Winzer; Frank R Heinzel; Axel Linke; Ruth H Strasser; Kun Zhang; Felix M Heidrich Journal: J Clin Med Date: 2020-01-07 Impact factor: 4.241
Authors: M Joannidis; W Druml; L G Forni; A B J Groeneveld; P M Honore; E Hoste; M Ostermann; H M Oudemans-van Straaten; M Schetz Journal: Intensive Care Med Date: 2017-06-02 Impact factor: 17.440